Trial Profile
A randomized, open label, single-dose, double-cycle, double-crossover, fasting and feedbioequivalence trial of Rasagiline Mesylate tablets in healthy subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 Aug 2018
Price :
$35
*
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinsonian disorders
- Focus Adverse reactions
- 31 Aug 2018 New trial record